Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Head and Neck Neoplasms 4Hot Flashes 3Breast Neoplasms 3Pain 2Vomiting 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Oropharyngeal Neoplasms 1Neurotoxicity Syndromes 1Neuralgia 1Neoplasms 1Nausea 1Mucositis 1Lung Neoplasms 1Abnormalities, Radiation-Induced 1

Interventions

Dexamethasone 23Ondansetron 12Palonosetron 11Aprepitant 9Granisetron 7Olanzapine 5ramosetron 3netupitant, palosentron drug combination 3casopitant 3Radiotherapy 3fosaprepitant 2Thalidomide 2Prochlorperazine 2Electroacupuncture 2Dronabinol 2Analgesia 2Acupressure 2sinomenine 1netupitant 1lerisetron 1dolasetron 1dexamethasone acetate 1Tropisetron 1Therapeutics 1Taxes 1Tablets 1Surveys and Questionnaires 1Sugars 1Metoclopramide 1Hygiene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Vomiting × Gabapentin × Clear all
NCT00880191 2016-07-06

Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
430 enrolled 11 charts

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡